M&A Deal Summary |
|
|---|---|
| Date | 2016-06-21 |
| Target | Teva Pharmaceutical Industries - Generic Products |
| Sector | Life Science |
| Buyer(s) | Impax Laboratories |
| Sellers(s) | Teva Pharmaceutical Industries |
| Deal Type | Divestiture |
| Deal Value | 586M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1993 |
| Sector | Life Science |
| Employees | 1,290 |
| Revenue | 860M USD (2015) |
Impax Laboratories, Inc. is a technology-based, specialty pharmaceutical company that applies formulation and development techniques, as well as drug delivery technology, to the development, manufacture and marketing of bioequivalent pharmaceutical products. Impax operates in two segments. These include global pharmaceuticals and Impax pharmaceuticals. The global division develops, manufactures, and distributes generic products. The Impax division develops proprietary brand pharmaceutical products that the Company believes represent improvements to already-approved pharmaceutical products addressing the treatment of central nervous system disorders. Impax Laboratories, Inc. was formed in 1993 and is based in Hayward, California.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 6 |
| Sector (Life Science) | 6 of 6 |
| Type (Divestiture) | 4 of 4 |
| Country (Israel) | 1 of 1 |
| Year (2016) | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-08-10 |
Impax Laboratories - Daraprim
Hayward, California, United States Impax Laboratories - Daraprim is indicated for the treatment of toxoplasmosis in combination with a sulfonamide. The most common side effects that may occur with Daraprim include allergic reactions, blood disorders, tongue changes, blood in the urine, heart rhythm disorders, anorexia, and vomiting. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-01-30 |
CorePharma
Middlesex, New Jersey, United States CorePharma LLC is a manufacturer and marketer of more than 14 drugs in the U.S. CorePharma was founded in 1998 and is based in Middlesex, New Jersey. |
Sell | - |
| Category | Company |
|---|---|
| Founded | 1901 |
| Sector | Life Science |
| Employees | 35,001 |
| Revenue | 15.8B USD (2023) |
Teva Pharmaceutical Industries is a provider of pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Teva Pharmaceutical Industries was founded in 1901 and is based in Tel Aviv, Israel.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 9 |
| Sector (Life Science) | 4 of 8 |
| Type (Divestiture) | 4 of 8 |
| Country (Israel) | 3 of 4 |
| Year (2016) | 1 of 1 |
| Size (of disclosed) | 4 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-10-01 |
Representaciones e Investigaciones Medicas S.A. de C.V.
Mexico City, Mexico Representaciones e Investigaciones Medicas S.A. de C.V. is a pharmaceutical company. Rimsa designs, develops, manufactures and markets generic drug products. |
Buy | $2.3B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-08-02 |
Anda
Parsippany, New Jersey, United States Anda, Inc. is a distributor of generic pharmaceuticals. |
Buy | $500M |
